Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,800 Publications201,349 Funding7,267 Clinical research3

FiltersClear all

Status

Recruiting1
Completed1
Terminated1

Study type

Interventional3

Phase

Phase 2/33
Not applicable138
Not reported24
Phase 311
Phase 28
Phase 46

Investigator

Conor Liston1
Rajiv S. Magge1
Uqba Khan1

Department

Medicine1
Neurology1
Psychiatry1

Condition

Colonic Neoplasms1
Depression1
Depressive Disorder, Major1
Gliosarcoma1
Suicidal Ideation1

Intervention type

Device3
Drug31
Biological7
Procedure7
Radiation4
Other2

Sponsor type

Other academic1
Industry1
NIH1

Start date

to

Has results posted1

Phase 2/3×Device×Clear all

Showing 1–3 of 3 studiesSort:

RecruitingInterventional · Phase 2/3NCT05174169 ↗
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Uqba Khan

Genetic

1

PI

Intervention: Device: Signatera test · Drug: mFOLFOX6 3-6 month · Drug: CAPOX 3 month · Drug: mFOLFIRINOX · Drug: mFOLFOX6 6 month · Drug: CAPOX 6 month
Dates: Jul 2022 – Mar 2029 (est.)
Sponsor: NRG Oncology

Stage III Colon Cancer

TerminatedInterventional · Phase 2/3NCT03693105 ↗

A Multi-Site, Randomized, Double-Blind Trial Assessing The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition

Intervention: Device: Active SAINT Stimulation · Device: Sham SAINT Stimulation
Dates: Jun 2024 – Mar 2025
Sponsor: Magnus Medical, Inc.

Major Depressive DisorderMajor Depressive EpisodeSuicidal Ideation

CompletedInterventional · Phase 2/3NCT04396860 ↗

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma

Rajiv S. MaggePI

Intervention: Procedure: Contrast-enhanced Magnetic Resonance Imaging · Biological: Ipilimumab · Biological: Nivolumab · Device: NovoTTF-100A Device · Other: Quality-of-Life Assessment · Other: Questionnaire Administration · Radiation: Radiation Therapy · Drug: Temozolomide
Dates: Sep 2020 – Jan 2023· Results posted
Sponsor: NRG Oncology

GliosarcomaMGMT-Unmethylated Glioblastoma